Establishment of a novel objective and quantitative method to assess pain-related behavior in monosodium iodoacetate-induced osteoarthritis in rat knee

Journal of Pharmacological and Toxicological Methods

Volumn 65, Issue 1, 2012, Pages 29-36

  Nagase, Hiroyuki ^a   Kumakura, Seiichiro ^a   Shimada, Kohei ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

Analgesic; Methods; Osteoarthritis; Pain; Rat; Spontaneous activity

Indexed keywords

AMITRIPTYLINE; CELECOXIB; GABAPENTIN; MORPHINE SULFATE; NAPROXEN; PARACETAMOL; TRAMADOL;

ANALGESIC ACTIVITY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; BONE DENSITY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESISTANCE; DRUG SENSITIVITY; HISTOPATHOLOGY; JOINT DEGENERATION; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; MALE; MOVEMENT (PHYSIOLOGY); NONHUMAN; PAIN; PAIN ASSESSMENT; PREDICTION; QUANTITATIVE ANALYSIS; RAT; SEDATION; SINGLE DRUG DOSE;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BEHAVIOR, ANIMAL; BONE DENSITY; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; INFLAMMATION; IODOACETATES; KNEE JOINT; MALE; OSTEOARTHRITIS, KNEE; PAIN; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; RATTUS;

EID: 84857039842     PISSN: 10568719     EISSN: 1873488X     Source Type: Journal    
DOI: 10.1016/j.vascn.2011.10.002     Document Type: Article

References (39)

1. Backonja M., Beydoun A., Edwards K.R., Schwartz S.L., Fonseca V., Hes M., et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial. Journal of the American Medical Association 1998, 280:1831-1836.
2. Bennett M.I., Simpson K.H. Gabapentin in the treatment of neuropathic pain. Palliative Medicine 2004, 18:5-11.
3. Bjordal J.M., Klovning A., Ljunggren A.E., Slordal L. Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: A meta-analysis of randomised placebo-controlled trials. European Journal of Pain 2007, 11:125-138.
4. Bjordal J.M., Ljunggren A.E., Klovning A., Slordal L. Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: Meta-analysis of randomised placebo controlled trials. BMJ 2004, 329:1317.
5. Bove S.E., Calcaterra S.L., Brooker R.M., Huber C.M., Guzman R.E., Juneau P.L., et al. Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis. Osteoarthritis and Cartilage 2003, 11:821-830.
6. Chandran P., Pai M., Blomme E.A., Hsieh G.C., Decker M.W., Honore P. Pharmacological modulation of movement-evoked pain in a rat model of osteoarthritis. European Journal of Pharmacology 2009, 613:39-45.
7. Clarke K.A., Heitmeyer S.A., Smith A.G., Taiwo Y.O. Gait analysis in a rat model of osteoarthrosis. Physiology and Behavior 1997, 62:951-954.
8. Combe R., Bramwell S., Field M.J. The monosodium iodoacetate model of osteoarthritis: A model of chronic nociceptive pain in rats?. Neuroscience Letters 2004, 370:236-240.
9. Creamer P., Lethbridge-Cejku M., Hochberg M.C. Where does it hurt? Pain localization in osteoarthritis of the knee. Osteoarthritis and Cartilage 1998, 6:318-323.
10. Felson D.T., Chaisson C.E., Hill C.L., Totterman S.M., Gale M.E., Skinner K.M., et al. The association of bone marrow lesions with pain in knee osteoarthritis. Annals of Internal Medicine 2001, 134:541-549.
11. Fernihough J., Gentry C., Malcangio M., Fox A., Rediske J., Pellas T., et al. Pain related behaviour in two models of osteoarthritis in the rat knee. Pain 2004, 112:83-93.
12. Gaspani L., Bianchi M., Limiroli E., Panerai A.E., Sacerdote P. The analgesic drug tramadol prevents the effect of surgery on natural killer cell activity and metastatic colonization in rats. Journal of Neuroimmunology 2002, 129:18-24.
13. Gilron I., Bailey J.M., Tu D., Holden R.R., Weaver D.F., Houlden R.L. Morphine, gabapentin, or their combination for neuropathic pain. The New England Journal of Medicine 2005, 352:1324-1334.
14. Guingamp C., Gegout-Pottie P., Philippe L., Terlain B., Netter P., Gillet P. Mono-iodoacetate-induced experimental osteoarthritis: A dose-response study of loss of mobility, morphology, and biochemistry. Arthritis and Rheumatism 1997, 40:1670-1679.
15. Guzman R.E., Evans M.G., Bove S., Morenko B., Kilgore K. Mono-iodoacetate-induced histologic changes in subchondral bone and articular cartilage of rat femorotibial joints: An animal model of osteoarthritis. Toxicologic Pathology 2003, 31:619-624.
16. Hannan M.T., Felson D.T., Pincus T. Analysis of the discordance between radiographic changes and knee pain in osteoarthritis of the knee. Journal of Rheumatology 2000, 27:1513-1517.
17. Haywood L., McWilliams D.F., Pearson C.I., Gill S.E., Ganesan A., Wilson D., et al. Inflammation and angiogenesis in osteoarthritis. Arthritis and Rheumatism 2003, 48:2173-2177.
18. Hinton R., Moody R.L., Davis A.W., Thomas S.F. Osteoarthritis: Diagnosis and therapeutic considerations. American Family Physician 2002, 65:841-848.
19. Inglis J.J., McNamee K.E., Chia S.L., Essex D., Feldmann M., Williams R.O., et al. Regulation of pain sensitivity in experimental osteoarthritis by the endogenous peripheral opioid system. Arthritis and Rheumatism 2008, 58:3110-3119.
20. Jones C.K., Peters S.C., Shannon H.E. Efficacy of duloxetine, a potent and balanced serotonergic and noradrenergic reuptake inhibitor, in inflammatory and acute pain models in rodents. Journal of Pharmacology and Experimental Therapeutics 2005, 312:726-732.
21. Kalbhen D.A. Chemical model of osteoarthritis-A pharmacological evaluation. Journal of Rheumatology 1987, 14:130-131. Spec No.
22. Matson D.J., Broom D.C., Carson S.R., Baldassari J., Kehne J., Cortright D.N. Inflammation-induced reduction of spontaneous activity by adjuvant: A novel model to study the effect of analgesics in rats. Journal of Pharmacology and Experimental Therapeutics 2007, 320:194-201.
23. Mikami Y., Okano H., Sakaguchi M., Nakamura M., Shimazaki T., Okano H.J., et al. Implantation of dendritic cells in injured adult spinal cord results in activation of endogenous neural stem/progenitor cells leading to de novo neurogenesis and functional recovery. Journal of Neuroscience Research 2004, 76:453-465.
24. Mikami Y., Toda M., Watanabe M., Nakamura M., Toyama Y., Kawakami Y. A simple and reliable behavioral analysis of locomotor function after spinal cord injury in mice. Technical note. Journal of Neurosurgery 2002, 97:142-147.
25. Munro G. Pharmacological assessment of the rat formalin test utilizing the clinically used analgesic drugs gabapentin, lamotrigine, morphine, duloxetine, tramadol and ibuprofen: Influence of low and high formalin concentrations. European Journal of Pharmacology 2009, 605:95-102.
26. Nagakura Y., Okada M., Kohara A., Kiso T., Toya T., Iwai A., et al. Allodynia and hyperalgesia in adjuvant-induced arthritic rats: Time course of progression and efficacy of analgesics. Journal of Pharmacology and Experimental Therapeutics 2003, 306:490-497.
27. Orito K., Kurozumi S., Ishii I., Tanaka A., Sawada J., Matsuda H. A sensitive gait parameter for quantification of arthritis in rats. Journal of Pharmacological Sciences 2007, 103:113-116.
28. Petrella R.J., DiSilvestro M.D., Hildebrand C. Effects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee: A randomized, double-blind, placebo-controlled clinical trial. Archives of Internal Medicine 2002, 162:292-298.
29. Pomonis J.D., Boulet J.M., Gottshall S.L., Phillips S., Sellers R., Bunton T., et al. Development and pharmacological characterization of a rat model of osteoarthritis pain. Pain 2005, 114:339-346.
30. Pulichino A.M., Rowland S., Wu T., Clark P., Xu D., Mathieu M.C., et al. Prostacyclin antagonism reduces pain and inflammation in rodent models of hyperalgesia and chronic arthritis. Journal of Pharmacology and Experimental Therapeutics 2006, 319:1043-1050.
31. Read S.J., Dray A. Osteoarthritic pain: A review of current, theoretical and emerging therapeutics. Expert Opinion on Investigational Drugs 2008, 17:619-640.
32. Rowbotham M., Harden N., Stacey B., Bernstein P., Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial. Journal of the American Medical Association 1998, 280:1837-1842.
33. Sinkov V., Cymet T. Osteoarthritis: Understanding the pathophysiology, genetics, and treatments. Journal of the National Medical Association 2003, 95:475-482.
34. Taniguchi N., Kanai S., Kawamoto M., Endo H., Higashino H. Study on application of static magnetic field for adjuvant arthritis rats. Evidence-Based Complementary, and Alternative Medicines 2004, 1:187-191.
35. Tonussi C.R., Ferreira S.H. Tumour necrosis factor-alpha mediates carrageenin-induced knee-joint incapacitation and also triggers overt nociception in previously inflamed rat knee-joints. Pain 1999, 82:81-87.
36. Torres L., Dunlop D.D., Peterfy C., Guermazi A., Prasad P., Hayes K.W., et al. The relationship between specific tissue lesions and pain severity in persons with knee osteoarthritis. Osteoarthritis and Cartilage 2006, 14:1033-1040.
37. van de Vusse A.C., Stomp-van den Berg S.G., Kessels A.H., Weber W.E. Randomised controlled trial of gabapentin in complex regional pain syndrome type 1 [ISRCTN84121379]. BMC Neurology 2004, 4:13.
38. van der Kraan P.M., Vitters E.L., van Beuningen H.M., van den Berg W.B. Proteoglycan synthesis and osteophyte formation in 'metabolically' and 'mechanically' induced murine degenerative joint disease: An in-vivo autoradiographic study. International Journal of Experimental Pathology 1992, 73:335-350.
39. Vonsy J.L., Ghandehari J., Dickenson A.H. Differential analgesic effects of morphine and gabapentin on behavioural measures of pain and disability in a model of osteoarthritis pain in rats. European Journal of Pain 2009, 13:786-793.